Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma

BACKGROUND: Mepolizumab, a humanized antibody targeting interleukin-5, decreases the number of blood eosinophils and the frequency of exacerbation of severe asthma. Galectin-10 is a protein within the cytoplasm of eosinophils and constitutes Charcot-Leyden crystals, which promotes key features of as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Konomi, Nagase, Hiroyuki, Sugimoto, Naoya, Yamamoto, Shiho, Tanaka, Akihiko, Fukunaga, Koichi, Atsuta, Ryo, Tagaya, Etsuko, Hojo, Masayuki, Gon, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331256/
https://www.ncbi.nlm.nih.gov/pubmed/34386407
http://dx.doi.org/10.5415/apallergy.2021.11.e31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331256/
https://www.ncbi.nlm.nih.gov/pubmed/34386407
http://dx.doi.org/10.5415/apallergy.2021.11.e31

Ejemplares similares